X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

ADVANCES IN THERAPY

期刊標題檢索 ADV THER 最新評論: How tall are you? (2024-04-26)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[ADVANCES IN THERAPY]您好,您是該頁面的第 31156 位訪客。

期刊簡介
期刊名稱ADVANCES IN THERAPY ADVANCES IN THERAPY
LetPub Score
6.6
50 ratings
Rate

Reputation
7.6

Influence
5.2

Speed
9.4

期刊簡稱ADV THER
ISSN0741-238X
E-ISSN1865-8652
h-index53
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.201.0891.316
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pharmacology (medical)
Q152 / 272

自引率 (2023-2024)2.90%自引率趨勢
掲載範囲
Advances in Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.

The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Advances in Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.
官方網站https://www.springer.com/12325
在線稿件提交https://www.editorialmanager.com/adth
開放訪問No
出版商Springer Healthcare
主題領域医学
出版國/地區ENGLAND
發行頻率月刊
創刊年2000
每年文章數345每年文章數趨勢
黃金OA百分比68.88%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ276/189
PHARMACOLOGY & PHARMACYSCIEQ2105/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0741-238X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【ADVANCES IN THERAPY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.70
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 26.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 28.10
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 23.90
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 23.00
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.30
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.70
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 11.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 15.40
    學科內最受檢索的期刊 頁面查看次數
    BIOMEDICINE & PHARMACOTHERAPY498338
    PHYTOMEDICINE340367
    LIFE SCIENCES285849
    International Journal of Pharmaceutics242444
    PHARMACOLOGICAL RESEARCH241359
    European Journal of Pharmacology204251
    BIOCHEMICAL PHARMACOLOGY202704
    JOURNAL OF NATURAL PRODUCTS196697
    BRITISH JOURNAL OF PHARMACOLOGY165150
    MOLECULAR PHARMACEUTICS162838
  •  

    ADVANCES IN THERAPY ADVANCES IN THERAPY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [ADVANCES IN THERAPY] 的評論撰寫評論
作者: Simon Kent


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-26 16:01:02 評論於
How tall are you?
(0) 讚! | Simon Kent

作者: 北国瑞绣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-02 18:16:43 評論於
Really
(0) 讚! | 北国瑞绣

作者: chenzhuer33


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2023-01-28 11:46:26 評論於
Advantages: The review process is fast, and the review comments are relatively fair. After revision, the paper is directly accepted. It requires rich data and a certain level of innovation in the articles. The number of Chinese submissions is generally moderate, not excessive, ensuring the quality of the magazine.

Disadvantages: The publication fees are extremely high, which are related to the length of the article. The more pages, the higher the cost, usually exceeding $5000.
(2) 讚! | chenzhuer33

作者: 珉林醉天


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-31 13:17:17 評論於
Review speed: 12.0 | Submission acceptance rate: 25.0
Experience sharing: It's not easy to review good and expensive
(0) 讚! | 珉林醉天

作者: 邻家文乐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-25 22:46:14 評論於
Do I need to pay the publication fee even if this journal does not accept my submission?
(0) 讚! | 邻家文乐

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 23:18:41 評論於
You can determine if your submission matches the journal's guidelines by referring to the article types outlined in the submission guidelines
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 19:02:00 評論於
Whether the topic of the manuscript is in line with the scope defined by the journal; the target audience of the journal; the peer-review and publication cycle of the journal
(0) 讚! | 维尔娜菲茨杰拉德

作者: 平原文波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 11:44:07 評論於
Is there a relationship between the type of article and the selection of journal?
(0) 讚! | 平原文波

作者: Darlene Pepys


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 20:33:23 評論於
Are there any principles when selecting publications?
(0) 讚! | Darlene Pepys

作者: 黑沙沙羽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-01-08 19:54:25 評論於
Yes, the manuscript must first undergo a quick review before being sent to external review
(0) 讚! | 黑沙沙羽

作者: 黑沙沙羽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-10-19 08:28:00 評論於
Yes, I remember it was around 20,000 for the OA fee and 30,000 for the expedited review fee. The expedited review fee must be paid, the key is that this fee cannot be reimbursed
(0) 讚! | 黑沙沙羽

作者: 凌波倩秀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-10-16 16:49:45 評論於
Hello, do you confirm all these expenses?
(0) 讚! | 凌波倩秀

作者: 黑沙沙羽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-06-26 08:33:31 評論於
Hello, may I ask if it is necessary to pay a quick service fee for this magazine? I see that they require a quick service fee, almost costing about 50,000 yuan, not including the OA fee, which requires an additional payment of 20,000 yuan
(0) 讚! | 黑沙沙羽

作者: 辉夜碧秋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-06-12 11:18:24 評論於
It seems like the official website says it's open choice
(0) 讚! | 辉夜碧秋

作者: 打狗朱莉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-05-21 12:29:57 評論於
How much does it cost
(0) 讚! | 打狗朱莉

作者: 苍风静涵


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-05-02 19:06:24 評論於
Efficient, received in a month and a half. The layout fee is very expensive, $660 per page, and additional charges for choosing open access. Most articles are sponsored by companies. Few Chinese people post on it, so there is no need to worry about Chinese people spamming
(0) 讚! | 苍风静涵

作者: 无极茂彦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-04-01 22:01:34 評論於
Review speed: 2.0 Experience sharing: When submitting the manuscript of a clinical study, it was initially submitted to Clinical Drug Investigation. The editor recommended submitting to this journal instead, and they could help with the transfer. However, we ultimately did not agree due to the expensive publication fee. Now, we have submitted to this journal again, and it is currently under review. We are unsure if it will be accepted
(0) 讚! | 无极茂彦

作者: 应龙铁磊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-02-12 11:05:26 評論於
Is it true that the layout fee is very high?
(0) 讚! | 应龙铁磊

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 13:55:41 評論於
One can only hope for next year, after all, as long as the overall trend is up, there is no need to worry. Even if it only increases a little bit each year, it will all add up over time
(0) 讚! | 凌霄高洁

作者: Anonymous


領域: 医药科学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2016-07-07 17:26:51 評論於
I primarily study drug efficacy for my PhD, and my most recent paper focused on a head-to-head comparison of the efficacy and safety of two drugs. I needed to get my research published to finish, so I was searching for a journal with a fast review period. The review time advertised for this journal is around 2 months, which is relatively quick. I submitted my manuscript to this journal and within three weeks I had a reply from the editor and two peer reviews. After I completed the revisions, the editorial department said that one of the reviewers had some reservations regarding my revisions. Despite this issue, the editor accepted my article. The entire process took a total of one and a half months – not terrible.

(0) 讚! | Anonymous

作者: 落雁歌韵


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-07-07 10:11:33 評論於
Research direction: Drug efficacy
Review time: Approximately 2 months
Just submitted a paper, comparing the efficacy and safety of two drugs head-to-head. Received comments in 3 weeks from 2 reviewers. After revision, the editorial department mentioned that one reviewer had some reservations about one of the responses. Made further revisions and finally accepted. Overall, it took about 1 and a half months
(0) 讚! | 落雁歌韵

作者: Clyde Scripps


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-01-15 23:04:39 評論於
Review Speed: 2.0 Experience Sharing: Just submitted a paper comparing the effectiveness and safety of two drugs. Received a response in 3 weeks from 2 reviewers. After revisions, the editorial board mentioned one reviewer had some reservations about a response, made further changes, and it was accepted. The whole process took a month and a half. The editorial board seemed very polite and patient
(0) 讚! | Clyde Scripps

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-09-08 17:30:27 評論於
Review speed: 12.0 | Submission hit rate: 25.0 Experience sharing: Rejected once, took three months to revise. Continued to submit, given major revisions. Accepted upon resubmission. Took one year. The publication fee is somewhat high
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-08-19 19:38:17 評論於
Review speed: 12.0 | Submission success rate: 25.0
Experience sharing: Damn it, after waiting for nearly half a year for the review, there were no comments given and the submission was directly rejected
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-08-06 20:00:32 評論於
Review Speed: 6.0 | Submission Acceptance Rate: 25.0
Experience Sharing: The review process is too slow, and the rejection rate is very high
(0) 讚! | 凌霄高洁

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [ADVANCES IN THERAPY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*